Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: Effect on eosinophil density and activation in relation to pharmacokinetics

BACKGROUND: We have previously demonstrated the clinical efficacy of montelukast in a randomized double-blind controlled cross-over trial in patients with dyspepsia in association with duodenal eosinophilia. The mechanism of this clinical response is unknown but could involve a decrease in eosinophi...

Descripción completa

Detalles Bibliográficos
Autores principales: Friesen, Craig A, Neilan, Nancy A, Schurman, Jennifer V, Taylor, Debra L, Kearns, Gregory L, Abdel-Rahman, Susan M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685805/
https://www.ncbi.nlm.nih.gov/pubmed/19432972
http://dx.doi.org/10.1186/1471-230X-9-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685805/
https://www.ncbi.nlm.nih.gov/pubmed/19432972
http://dx.doi.org/10.1186/1471-230X-9-32

Ejemplares similares